Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position the company at the forefront of the Pharma 4.0 ...
“The KickStart Grant Awards help de-risk these technologies by establishing a collaboration agreement between the startup ...
Accelerated fourth quarter sales growth to 13.5%Fourth quarter gross margin expanded 310 bps and adjusted gross margin* expanded 230 bpsFourth quarter cash from operations of $19.3 million increased ...
"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.
Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. GLOW2 study design mirrors GLOW1 study, which met primary endpoint and all key secondary ...
The Palm Springs Post on MSN10h
Safety Blows? Palm Springs-based initiative gains momentum, hands out 8,000 whistlesIn response to rising threats, a local psychotherapist has distributed thousands of whistles, aiming to create safer spaces ...
The at-long-last-decision to write his memoirs, was quite a daunting one for General Babangida, who has over the years, ...
Many critical functions of the food division of the Food and Drug Administration have been drastically slowed or entirely stopped since late ...
Marty Makary is one step closer to becoming the head of the Food and Drug Administration. On March 13, the Senate Health, ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...
Four-star-rated analyst Daniel Grosslight at Citi reiterated his Sell rating on Hims & Hers Health (HIMS) stock yesterday, ...
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback